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recovery after SCI in rats. Moreover, the peptide modiﬁcation in the hy-
drogel demonstrated to highly improve its capacity to promote neuro-
nal repair. Animals showed signiﬁcant improvements on BBB scale,
rearing activity, and motor coordination. These results indicate that this
strategy may have therapeutic beneﬁt for SCI repair.
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The development of drug delivery systems (DDS) for targeted intracel-
lular delivery of therapeutic agents has been attracting great deal of
attention. In traumatic central nervous system conditions, where thera-
pies have been revealing to be highly inneﬁcient and non-speciﬁc, these
targeted DDS could be highly beneﬁcial. We have previously shown in
vitro studies where the carboxymethylchitosan (CMCht)/ poly(amido-
amine) (PAMAM) nanoparticles (NPs) were able to be uptaken by dif-
ferent cell types (neurons and glial cells), while not evidencing any
cytotoxicity. In the present study, in vivo biodistribution of the CMCht/
PAMAM NPs was investigated. Following intravenous injection in adult
male Wistar rats, the NPs showed to be stable in circulation and able to
be internalized by cells from different tissues (e.g., brain, liver, kidney
and lung). Afterwards, methylprednisolone (MP)-loaded ﬂuorescently-
labelled NPs were administered in the cerebrospinal ﬂuid of the cis-
terna magna of adult male Wistar rats. Upon the intracisternal injec-
tion, NPs were detected throughout the cortical and parenchimal areas
of the brain, namely in the prefrontal cortex, hippocampus and peri-
ventricular areas after 24 h. More recently, ongoing studies are focusing
on the therapeutic value of these methylprednisolone-loaded NPs
administered following a spinal cord lesion in rats. Signiﬁcant differ-
ences in the BBB locomotory test were found in MP-NPs treated rats
1 month after injury.
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Spinal cord injury (SCI) is a major cause of paralysis. Currently, there
are no effective therapies to reverse this disabling condition. Recently
we have shown that acute transplantation of ependymal stem/progeni-
tor cells (epSPC) –spinal cord-derived neural precursors- rescue lost
neurological function after SCI in rodents. However, in a chronic sce-
nario, with axon repulsive reactive scar, a combinatorial approach is
necessary. The integration of biomaterial scaffolds for a physical sup-
port with the cell-replacement therapy and pharmacological treatments
to protect and induce neuronal survival offers a good formula for
chronic SCI regeneration. Here we show a new application of caprolac-
tone 2-(methacryloyloxy)ethyl ester (CLMA) as porous scaffolds. The
epSPC can growth and expand into the scaffolds in the presence of
EGF and FGF, however signiﬁcant reduction on the cell population was
achieved after 6 days in vitro (DIV). FM19G11, ﬁrst described as a HIFa
protein inhibitor, which is able to allow progenitor cells to differentiate
under hypoxia, under normoxic conditions induces self-renewal. epSPC
growth in CLMA scaffolds in the presence of FM19G11 signiﬁcantly
divide more at 6 DIV than the ones treated with vehicle alone. Stronger
protein expression of oligodendrocyte precursor cells occurs by
FM19G11 treatment. Overall, epSPC seeded in CLMA scaffolds and
activated by FM19G11 would offer a good combination for the chronic
SCI treatments. Work supported by FISS PI10/01683.
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Combined therapy using hydrogels and stem cells seems to be a prom-
ising approach to restoring damaged tissue following spinal cord injury
(SCI). Mesenchymal stem cells (MSC) were seeded on 4 different hy-
drogels: hydroxy propyl methacrylate-RGD prepared by heterophase
separation (HPMA-RGD-HS) and 3 other hydrogels polymerized in the
presence of a solid porogen: HPMA-SP, HPMA-RGD-SP and hydroxy
ethyl methacrylate [2-(methacryloyloxy)ethyl] trimethylammonium
chloride (HEMA-MOETACl). Cell adhesion and survival were evaluated
1, 7 and 14 days after the seeding of MSCs on the hydrogel scaffolds.
HEMA-MOETACl and HPMA-RGD-SP hydrogels were superior in the
number of cells attached in vitro. Cell-polymer scaffolds were then
implanted into hemisected rat spinal cords for 1 month. The best sur-
vival of MSCs was found in HEMA-MOETACl hydrogels; however, only
a small ingrowth of blood vessels and axons was observed. Both
HPMA-SP hydrogels showed better survival of MSCs compared to the
HPMA-RGD-HS hydrogel. Both RGD-attached hydrogels contained sig-
niﬁcantly higher numbers of blood vessels. Further, both HPMA-SP hy-
drogels promoted a signiﬁcantly greater ingrowth of axons into the
implant. Our results demonstrate that the physical and chemical prop-
erties of HPMA-RGD-SP hydrogels result in the best combined effect in
serving as a stem cell carrier and a bridging material for the treatment
of SCI.Supported by: AV0Z50390703, IAA 500390902, P304/11/P633
and P108/10/1560
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Research into the utility of nanoﬁbres in neural tissue engineering has
overwhelmingly relied on the use of basic 2D culture models employ-
ing cell lines and monocultures. This ‘proof-of-principle’ study reports
the fabrication of 3D nanoﬁbre-hydrogel constructs for alignment and
co-culture of the major glial cell subpopulations (viz. astrocytes, OPCs/
oligodendrocytes and microglia). Electrospun aligned, ﬂuorescent PLA
nanoﬁbres were transferred to portable acetate frames that permitted
their layering onto hydrogels. A single nanoﬁbre layer was used to
quantify the elongation (aspect ratios) of individual cells from pure,
primary astrocyte, OPC cultures, or their co-cultures, compared with
control hydrogel constructs. Astrocytes showed attachment and align-
ment on nanoﬁbres and displayed healthy nuclei with evidence of cell
proliferation. OPCs showed poor survival on hydrogels alone or those
containing nanoﬁbres. However, the survival, proliferation and elonga-
tion of OPCs was pronounced in co-cultures with astrocytes, with differ-
entiation into oligodendrocytes after an extended culture period.
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